Skip to main content

FreeCME
About Us
Sign Up|Log In

FreeCME
About Us
All Products

Sign Up|Log In

Browse by Speciality Area

Hospital Medicine
Cardiology
Risk Management
Emergency Medicine
Infectious Disease
Internal Medicine
Neurology
Primary Care
Medical Ethics
Pediatrics

Browse by Product Type

Subscription Publications
Books & Study Guides

All Access Subscription

Get unlimited access to our full publication and article library.

Interested in Group Sales? Learn more

Home
Drug Formulary Review Archives
January 1, 2001

Drug Criteria & Outcomes: Levetiracetam (Keppra) for treatment of partial seizures

January 1, 2001

Issue Date: January 1, 2001

Table of Contents

What does DUR mean to you? Definitions and purposes abound
UHC to implement Zynx Health information tools
Alosetron tablets removed from market
More ‘supplemental’ news: Tiratricol is trouble
Drug Criteria & Outcomes: Levetiracetam (Keppra) for treatment of partial seizures
Drug Criteria & Outcomes: Calfactant (Infasurf)for respiratory distress
Drugs in the Pipeline
New FDA Approvals

Financial Disclosure: None of the authors or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients

Shop Now: Search Products

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements

Emergency
Hospital
Clinical
All Access
Help
Search
About Us
Newsletters
FreeCME

The trusted source for healthcare information and CONTINUING EDUCATION.

ACCOUNTS RECEIVABLE

MAILING ADDRESS

1010 Sync St., Suite 100

Morrisville, NC 27560-5468

USA

© 2025 Relias. All rights reserved.

Do Not Sell My Personal Information
Privacy Policy
Terms Of Use
Help
Group Sales

For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com